Hubei Jumpcan Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Hubei Jichuan Pharmaceutical Co., Ltd. is a national high-tech enterprise group that integrates the three major industries of Western medicine, traditional Chinese medicine daily chemical, and traditional Chinese medicine healthcare. It is a backbone enterprise in the pharmaceutical industry of the National Torch Plan, a top 100 enterprise in the national pharmaceutical industry, and an A-share listed company on the Shanghai Stock Exchange. The stock code is 600566. The company has jurisdiction over Jichuan Pharmaceutical Group Co., Ltd. and Shanghai Jijia Investment Co., Ltd. Jichuan Pharmaceutical Group Co., Ltd. has subsidiaries such as Tianji Pharmaceutical, Jiyuan Pharmaceutical, Pudi Lan Daily Chemical, E-commerce Company, Kangxuyuan Health Products, Jiren Traditional Chinese Medicine Tablets, Ginkgo Industry Research Institute, and Oral Health Research Institute; Shanghai Jijia Investment Co., Ltd. has subsidiaries such as Ningbo Jijia Investment and Dongke Pharmaceutical. Jichuan Pharmaceutical promotes the corporate spirit of "working together and embracing all rivers" and the core values of "innovation, diligence, and win-win", adheres to the "Four Ones" value creation concept, practices the "Five Principles" talent concept of "talent as the foundation, talent as capital, treatment to attract talent, career to cultivate talent, and emotional retention of talent", advocates the "two requirements", and leads the development of the enterprise with a distinctive corporate culture. Jichuan Pharmaceutical adheres to the corporate mission of "using technology to protect health", advocates the research and development concept of "leading the forefront and innovating high-quality products", implements the new concept of "focusing on five major fields to promote development and innovating academic marketing", and focuses on the production and sales of drugs in pediatric, oral, respiratory, digestive, obstetrics and gynecology, and other fields. The company has a product group with more than 10 dosage forms and 210 specifications and varieties under the national drug license. There are more than 110 product specifications listed in the national medical insurance catalog, including Xiao'er Douqiao Qingre Granules (Tongbei), Jianwei Xiaoshi Oral Liquid, San'ao Tablets, and 68 product specifications listed in the national basic drug catalog. In 2020, three new varieties, Chuanxiong Qingnao Granules, Ganhai Weikang Capsules, and Levetiracetam Injection Concentrated Solution, were added to the national medical insurance catalog. More than 10 varieties such as Pudi Lan and Chuanxiong are exclusive domestic varieties, exclusive dosage forms, high-tech products in Jiangsu Province, and famous brand products in Jiangsu Province. The "Shoupai" trademark is a well-known trademark in China, and the "Tongxiao" trademark is a famous trademark in Jiangsu Province. Children's Fermented Soybean and Heat Clearing Granules (Tongbei) were awarded the "Pediatric Brand Most Recognized by Grass roots Doctors" respectively, and were selected as the traditional Chinese patent medicines and simple preparations brand of clinical value in 2020, becoming the brand with the highest recommendation rate of Chinese pharmacy staff; Pu Di Lan Anti Inflammation Oral Liquid has been awarded the "Most Popular Star Product" and "Recommended Product for Family Medication" by pharmacies, ranking first in the "Healthy China Brand List · Throat and Oral Medication Category" in 2020, and selected for the "Report on the Technological Competitiveness of Large Varieties of Traditional Chinese Medicine (2019)"; The new generation proton pump inhibitor rabeprazole sodium enteric coated capsules (Jinuo) were selected for the "2020 Chinese Medicine · Brand List"; Jianwei Xiaoshi Oral Liquid has been awarded the title of "Recommended Product with Same Source of Medicine and Food". The traditional Chinese medicine daily chemical products led by Pudi Lan Ke Yan Ning toothpaste, Pudi Lan Ke Yan Ning antibacterial mouthwash, and Pudi Lan Ke Yan Ning antibacterial oral spray continuously enhance the core competitiveness of the market and promote the rapid development of the great health cause. Jichuan Pharmaceutical responds to the Healthy China strategy and accelerates the promotion of industrial transformation and upgrading. With the vision of "scale, capitalization, and internationalization", and the value creation concept of "enterprises should have a certain development speed, employees should have a certain income growth, make a certain tax contribution to the government, and have a certain sense of responsibility and dedication to society and shareholders", Jichuan Pharmaceutical comprehensively implements the "three industries of traditional Chinese and Western medicine, traditional Chinese medicine daily chemical, and traditional Chinese medicine healthcare" and innovative scientific research The overall health strategy layout of capital operation supported by two wings promotes high-quality development of the "two hundred years, two ten billion" double hundred strategy. |
| Headquarter | Jingzhou |
| Establish Date | 1/22/1997 |
| Listed Code | 600566.SH |
| Listed Date | 8/22/2001 |
| Chairman | Cao Longxiang. |
| CEO | Cao Fei. |
| Website | www.jumpcan.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
